|
GavisconDrug - Gaviscon The trade name of the product as shown on the labeling.
Dosage -
TABLET, CHEWABLE; ORAL
Active Ingredient(s) -
Aluminum Hydroxide; Magnesium Trisilicate
Strength -
160MG;40MG
Applicant -
AVENTIS PHARMS
New Drug Application (NDA) Number -
018685
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 9, 1983
Reference Listed Drug (RLD) -
Yes
Type -
OTC
Applicant Full Name -
Aventis Pharmaceuticals Inc
Gaviscon
Muse 0.25mg Suppository; Urethral
Muse 0.5mg Suppository; Urethral Muse 1mg Suppository; Urethral Rautensin 2mg Tablet; Oral Rauwiloid 2mg Tablet; Oral Hexalen 50mg Capsule; Oral Aluminum Hydroxide And Magnesium Trisilicate 80mg;20mg Tablet, Chewable; Oral Foamcoat 80mg;20mg Tablet, Chewable; Oral Foamicon 80mg;20mg Tablet, Chewable; Oral Gaviscon 160mg;40mg Tablet, Chewable; Oral NewDrugInformation |